This NDC is on FDA's drug shortage list (posted Dec 22, 2021)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.6802 per EA under NDC 42806079930. Its NADAC has been published 229 times since Apr 6, 2022.
FDA first approved this application on May 28, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Epic Pharma LLCNDC
42806079930
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA064150FDA Approved
5/28/1997
TE Code
AB
On Market Since
12/15/2021
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 229 times since Apr 6, 2022, and over the history we have for it it has declined 29.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6802 per EA |
|---|---|
| All-time high | $0.9590 (Apr 13, 2022) |
| All-time low | $0.4888 (Nov 20, 2024) |
| 52-week high | $0.7186 |
| 52-week low | $0.6802 |
| Median price | $0.6910 |
| Average price | $0.6819 |
| Largest weekly change | -29.8% (Apr 20, 2022) |
| Weeks tracked | 229 |
| Tracking since | Apr 6, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.6802 per EA (NDC 42806079930), effective Aug 19, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has declined 29.1%. It has been tracked across 229 weekly CMS publications since Apr 6, 2022.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since Apr 6, 2022, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.4888 (Nov 20, 2024) to a high of $0.9590 (Apr 13, 2022), with a median of $0.6910 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIFAMPIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 42806079930) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.
Is RIFAMPIN 300 MG CAPSULE in shortage?
Yes — NDC 42806079930 is currently listed in FDA's drug shortage database (posted Dec 22, 2021). Reported reason: Discontinuation of the manufacture of the drug.